Martin G. Pomper

38.8k total citations · 5 hit papers
613 papers, 27.1k citations indexed

About

Martin G. Pomper is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Martin G. Pomper has authored 613 papers receiving a total of 27.1k indexed citations (citations by other indexed papers that have themselves been cited), including 289 papers in Radiology, Nuclear Medicine and Imaging, 212 papers in Pulmonary and Respiratory Medicine and 145 papers in Molecular Biology. Recurrent topics in Martin G. Pomper's work include Radiopharmaceutical Chemistry and Applications (180 papers), Prostate Cancer Treatment and Research (175 papers) and Medical Imaging Techniques and Applications (88 papers). Martin G. Pomper is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (180 papers), Prostate Cancer Treatment and Research (175 papers) and Medical Imaging Techniques and Applications (88 papers). Martin G. Pomper collaborates with scholars based in United States, Germany and China. Martin G. Pomper's co-authors include Steven P. Rowe, Ronnie C. Mease, Catherine A. Foss, Sangeeta Ray Banerjee, Sridhar Nimmagadda, Michael A. Gorin, Robert F. Dannals, Peter C.M. van Zijl, Mrudula Pullambhatla and Yuchuan Wang and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Martin G. Pomper

606 papers receiving 26.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson’s Disease

2019 961 citations Catherine A. Foss, Martin G. Pomper et al. profile →
Chemogenetics revealed: DREADD occupancy and activation via converted clozapine

2017 677 citations Martin G. Pomper et al. profile →
State-of-the-art in design rules for drug delivery platforms: Lessons learned from FDA-approved nanomedicines

2014 408 citations Luisa M. Russell, Martin G. Pomper et al. profile →
Initial Evaluation of [18F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer

2015 354 citations Steven P. Rowe, Mario A. Eisenberger et al. profile →
Molecular imaging in oncology: Current impact and future directions

2021 223 citations Steven P. Rowe, Martin G. Pomper CA A Cancer Journal for Clinicians profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Martin G. Pomper United States	86	11.1k	7.5k	6.0k	4.8k	3.3k	613	27.1k
Brian D. Ross United States	80	11.7k 1.0×	3.0k 0.4×	6.4k 1.1×	1.6k 0.3×	2.7k 0.8×	462	26.6k
Wim J.G. Oyen Netherlands	87	12.9k 1.2×	6.2k 0.8×	5.8k 1.0×	7.2k 1.5×	2.3k 0.7×	689	30.8k
Markus Schwaiger Germany	124	35.1k 3.2×	14.9k 2.0×	6.3k 1.1×	7.5k 1.6×	4.9k 1.5×	1.1k	60.9k
Roger Stupp Switzerland	85	8.2k 0.7×	13.9k 1.8×	15.7k 2.6×	9.5k 2.0×	3.8k 1.2×	376	49.8k
Mark W. Dewhirst United States	105	8.9k 0.8×	6.0k 0.8×	18.2k 3.0×	8.7k 1.8×	14.3k 4.3×	627	48.6k
Martin J. van den Bent Netherlands	92	10.3k 0.9×	14.9k 2.0×	12.7k 2.1×	8.1k 1.7×	3.1k 0.9×	579	51.0k
Ralph R. Weichselbaum United States	107	5.5k 0.5×	10.6k 1.4×	17.9k 3.0×	18.7k 3.9×	5.0k 1.5×	707	48.4k
Peter Vaupel Germany	68	6.0k 0.5×	4.0k 0.5×	10.0k 1.7×	4.8k 1.0×	6.3k 1.9×	393	28.2k
Edward A. Neuwelt United States	66	2.6k 0.2×	2.9k 0.4×	3.1k 0.5×	2.7k 0.6×	2.1k 0.6×	326	17.2k
Abass Alavi United States	94	14.2k 1.3×	8.0k 1.1×	3.4k 0.6×	4.1k 0.9×	1.7k 0.5×	1.1k	37.2k

Countries citing papers authored by Martin G. Pomper

Since Specialization

Citations

This map shows the geographic impact of Martin G. Pomper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin G. Pomper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin G. Pomper more than expected).

Fields of papers citing papers by Martin G. Pomper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin G. Pomper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin G. Pomper. The network helps show where Martin G. Pomper may publish in the future.

Co-authorship network of co-authors of Martin G. Pomper

This figure shows the co-authorship network connecting the top 25 collaborators of Martin G. Pomper. A scholar is included among the top collaborators of Martin G. Pomper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin G. Pomper. Martin G. Pomper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Nisi, Jai Woong Seo, Elise Robinson, et al.. (2025). Development of an in situ CAR-T cell protocol through optical and PSMA-targeted PET imaging. Proceedings of the National Academy of Sciences. 122(24). e2504950122–e2504950122. 1 indexed citations

Hartrampf, Philipp E., Anna Katharina Seitz, Hubert Kübler, et al.. (2024). Prognostic Performance of RECIP 1.0 Based on [¹⁸F]PSMA-1007 PET in Prostate Cancer Patients Treated with [¹⁷⁷Lu]Lu-PSMA I&T. Journal of Nuclear Medicine. 65(4). 560–565. 8 indexed citations

Merino, Vanessa F., Yu Yan, Alvaro A. Ordoñez, et al.. (2023). Nucleolin mediates SARS-CoV-2 replication and viral-induced apoptosis of host cells. Antiviral Research. 211. 105550–105550. 20 indexed citations

Hartrampf, Philipp E., Anna Katharina Seitz, Hubert Kübler, et al.. (2023). SUVmean on baseline [18F]PSMA-1007 PET and clinical parameters are associated with survival in prostate cancer patients scheduled for [177Lu]Lu-PSMA I&T. European Journal of Nuclear Medicine and Molecular Imaging. 50(11). 3465–3474. 21 indexed citations

Vaughan, Hannah J., Desmond Jacob, Ronnie C. Mease, et al.. (2022). Polymeric nanoparticles for dual-targeted theranostic gene delivery to hepatocellular carcinoma. Science Advances. 8(29). eabo6406–eabo6406. 39 indexed citations

Zukotynski, Katherine, Urban Emmenegger, Sébastien J. Hotte, et al.. (2021). Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen–Targeted ¹⁸F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide. Journal of Nuclear Medicine. 62(10). 1430–1437. 34 indexed citations

Rowe, Steven P. & Martin G. Pomper. (2021). Molecular imaging in oncology: Current impact and future directions. CA A Cancer Journal for Clinicians. 72(4). 333–352. 223 indexed citations breakdown →

Paranjpe, Manish, Xueqi Chen, Min Liu, et al.. (2019). The effect of ApoE ε4 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: a FDG-PET study. NeuroImage Clinical. 22. 101795–101795. 39 indexed citations

Jiang, Shanshan, Charles G. Eberhart, Michael Lim, et al.. (2018). Identifying Recurrent Malignant Glioma after Treatment Using Amide Proton Transfer-Weighted MR Imaging: A Validation Study with Image-Guided Stereotactic Biopsy. Clinical Cancer Research. 25(2). 552–561. 114 indexed citations

10.

Mou, Tung‐Chung, Lucia Tamborini, Martin G. Pomper, et al.. (2017). Structural basis of subunit selectivity for competitive NMDA receptor antagonists with preference for GluN2A over GluN2B subunits. Proceedings of the National Academy of Sciences. 114(33). E6942–E6951. 39 indexed citations

11.

Kumar, Binod, Koji Hatano, Luisa M. Russell, et al.. (2016). Development and Application of a Novel Model System to Study “Active” and “Passive” Tumor Targeting. Molecular Cancer Therapeutics. 15(10). 2541–2550. 10 indexed citations

12.

Bhatnagar, Akrita, Yuchuan Wang, Ronnie C. Mease, et al.. (2014). AEG-1 Promoter–Mediated Imaging of Prostate Cancer. Cancer Research. 74(20). 5772–5781. 28 indexed citations

13.

Pullambhatla, Mrudula, Alexander T. Falk, Youngjoo Byun, et al.. (2011). 99mTc-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancer. 52(2). 293–293. 2 indexed citations

14.

Maschauer, Simone, Catherine A. Foss, Sridhar Nimmagadda, et al.. (2011). Effects of Recombinant Human Thyroid-Stimulating Hormone Superagonists on Thyroidal Uptake of ¹⁸ F-Fluorodeoxyglucose and Radioiodide. Thyroid. 21(7). 783–792. 12 indexed citations

15.

Wilson, Brice A. P., Haofan Wang, Benjamin A. Nacev, et al.. (2011). High-Throughput Screen Identifies Novel Inhibitors of Cancer Biomarker α-Methylacyl Coenzyme A Racemase (AMACR/P504S). Molecular Cancer Therapeutics. 10(5). 825–838. 44 indexed citations

16.

Chen, Ying, Mrudula Pullambhatla, Catherine A. Foss, et al.. (2011). 2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer. Clinical Cancer Research. 17(24). 7645–7653. 311 indexed citations

17.

Nimmagadda, Sridhar, et al.. (2010). Molecular Imaging of CXCR4 Receptor Expression in Human Cancer Xenografts with [64Cu]AMD3100 Positron Emission Tomography. Cancer Research. 70(10). 3935–3944. 104 indexed citations

18.

Zhang, Yimao, Youngjoo Byun, Yunzhao R. Ren, et al.. (2009). Identification of Inhibitors of ABCG2 by a Bioluminescence Imaging–Based High-Throughput Assay. Cancer Research. 69(14). 5867–5875. 34 indexed citations

19.

Zhang, Yimao, Joseph Bressler, Bachchu Lal, et al.. (2007). ABCG2/BCRP Expression Modulates d -Luciferin–Based Bioluminescence Imaging. Cancer Research. 67(19). 9389–9397. 67 indexed citations

20.

Pomper, Martin G. & John D. Port. (2001). NEW TECHNIQUES IN MAGNETIC RESONANCE IMAGING OF BRAIN TUMORS. Neuroimaging Clinics of North America. 11(3). 501–525. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact